Regular Check-ins on Glucose Data May Help Kids with Type 1 Diabetes Stay in Range

Researchers at Perth Children's Hospital in Western Australia wanted to know if regular, structured reviews of continuous glucose monitoring (CGM) data could help children with Type 1 diabetes manage their blood sugar more effectively. They compared two groups of children ages 5–14: one group received scheduled CGM reviews every 14 days with personalized feedback, while the other group received standard care.

The key idea was to focus educator time where it was most needed. Children whose time in range (glucose between 3.9–10.0 mmol/L) had dropped more than 10% from the previous period, or who weren't meeting standard glucose targets, were prioritized for one-on-one support via phone or email. Children who were doing well received encouraging text messages to reinforce their progress.

The study included 113 children: 60 in the intervention group and 53 in the control group. The children were similar in age (around 10 years old) and starting glucose control. About 72% of the intervention group and 64% of the control group were using automated insulin delivery systems—sometimes called 'artificial pancreas' systems—which deliver insulin automatically based on CGM readings.

Over the 6-month study period, the intervention group—those receiving the scheduled CGM reviews and targeted feedback—showed improvement in time in range compared to the control group. About 71% of children in the intervention group received at least one personalized contact from a diabetes educator during each 14-day period.

This study suggests that regular, structured check-ins on CGM data, combined with personalized guidance when needed, may help children with Type 1 diabetes stay closer to their glucose targets. The approach works within real-world limits—educators can't contact every child every week, so the study prioritized support for children showing declining control.

The findings also highlight the importance of both corrective feedback for children struggling to meet targets and positive reinforcement for those doing well. Most families in this study were using automated insulin delivery systems, so the results may reflect what's possible when CGM data and automated systems work together with regular professional oversight.

This is one study from two clinics in Australia, so more research is needed to understand how these results might apply in other settings and with different populations. The study measured changes in time in range and asked children and families about their satisfaction with treatment, but longer follow-up would help clarify whether these benefits persist over time.

If you're interested in how more frequent CGM reviews might support your child's diabetes management, discussing this approach with your diabetes care team is a good first step—they can advise what's practical and beneficial for your situation.

Source: Hormone research in paediatrics. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.